The Playground

    Quote from Mark U

    “Yes, we will get out of this pandemic by vaccination. We all know people who are a little bit hesitant. We will continue to try and convince them, but there are also people who are fiercely against vaccination,” said Trudeau.

    “They are [host : extremists ] who don’t believe in science, they’re often misogynists, also often racists. It’s a small group that muscles in, and we have to make a choice in terms of leaders, in terms of the country. Do we tolerate these people?

    This vaccine terror message is spread world wide despite the fact that vaccinated today spread the virus more often than unvaccinated...

    The fact is since day 1: The fascist big pharma vaccine terror mafia denies science since day one.

    - Not a single required safety test done by Pfizer - all test have been faked. (Moderna almost compliant!)

    - No real phase III study done by Pfizer. Moderna fine!

    - Single RNA gene therapy induces no proper immune memory. Moderna 2 RNA quite a bit.

    - RNA gene therapy is 1000x more damaging than the worst vaccine up to date...valid for all


    Just for the memory. Biontec (inside Pifzer) is a cancer chemo (gene therapy) research center since its foundation....

    For crying out load you really have become the ghost of John R. Huizenga. The experts you so love, disagree with you, are you calling them wrong? Based on what freaking data. Pinhead!!!



    The riddle of Japan's dramatic drop in COVID numbers


    NPR Cookie Consent and Choices


    In mid-August, not long after the Tokyo Olympics had wrapped up, the situation in Japan looked grim to Dr. Hideaki Oka, an infectious disease expert at the Saitama Medical University Hospital outside Tokyo.


    As he treated COVID-19 patients at his hospital, Japan was in the grip of a fifth wave of infections. New cases nationwide had surged to around 25,000 a day, and the country's medical system was being stretched to its limits.


    By late September, cases had plunged, and Oka is now getting a respite, of sorts.


    "We have had zero COVID patients in our hospital for two months straight," he explains, "so we've been able to concentrate on general medicine just as in pre-COVID times."


    The turnaround has been so dramatic it has left experts and observers struggling to explain it. Cases dropped by more than 99% from their peak. Japan has seen less than one death a day in recent weeks, its lowest level since July 2020.

    After the previous four waves of infections, almost as soon as local governments lifted their states of emergency, cases quickly began to rebound. But after the most recent state of emergency was lifted, on Sept. 28, there was no sudden rebound — or at least not yet.


    "We've had below 50 new cases [daily] on average for eight weeks," Dr. Norio Ohmagari, of Japan's National Center for Global Health and Medicine, told a meeting on Dec. 9. about the situation in Tokyo.


    His explanation: "We think it is due to countermeasures taken by many citizens and institutions, and accelerated vaccination, thanks to medical staffs' efforts and citizens' understanding."


    Oka says that the Olympics provided the political motivation for the administration of then-Prime Minister Yoshihide Suga to speed up its vaccine rollout ahead of the Games.


    Japan had lagged behind other developed nations earlier this year, but now nearly 80% of its population of 125 million people is fully vaccinated. It just started administering booster shots this month.


    The vaccine is one barrier keeping the virus at bay. Oka says that it's a social norm in Japan to keep another kind of barrier over people's mouths and noses.


    "Even though I keep having no COVID patients, I haven't seen anybody on the street in Japan not wearing masks," observers Oka. "Even though they think it may not be necessary, there is pressure for people to do the same as everyone else."


    Then again, Japan's neighbor South Korea has fully vaccinated more than 90% of its adult population. And masking up in public is the norm in that country too.


    But South Korea is going through its worst wave of infections of the pandemic so far. After a month and a half of gradual easing of restrictions, it had to reimpose limits on gatherings and business, starting on Dec. 3, with additional restrictions added on Dec. 16


    As was the case in the early months of the pandemic last year, Japan is trying to figure out why its COVID-19 case numbers and fatalities remain low by international standards.


    Few in Japan credit the government's response to the coronavirus. Despite accelerating the vaccine rollout, Suga was generally seen as being indecisive and too concerned about the economic impact of social distancing. He quit in September after less than a year in office.


    And as was the case last year, media and scientific journals continue to publish hypotheses about an "x-factor," some characteristic of Japan's people or its environment that has helped it escape more serious COVID-19 damage.


    "One hypothesis is that there is something intrinsically different about the immune cells that the Japanese people might carry that is able to fight off the infection," says Akiko Iwasaki, an immunologist at Yale University who, in a paper last year, tackled the question of "Why does Japan have so few cases of COVID-19?"


    In it, she mentions another hypothesis that says that a milder variant of the coronavirus was already circulating in Japan, giving some people immunity to SARS-CoV-2.


    Yet another theory, she adds, holds that the delta variant in Japan has mutated so that it has lost the ability to replicate, pushing itself toward extinction.


    Interesting as these hypotheses may be, Iwasaki says, "currently these are not proven theories."


    "Even if the theories are right," agrees Oka, "it is not possible for Japan to keep the country closed and blocked off to outsiders. This will not last forever. The reality is another wave will definitely come."


    To keep out the omicron variant, Japan closed its borders to nonresident foreigners last month, after briefly easing such restrictions, and case numbers appear to be creeping back up.


    Another wave of infections, Oka adds, could quickly lay to rest any speculation that Japan is somehow exceptional when it comes to COVID-19.

    Quote from THHuxleynew

    For omicron (where vaccines are least effective against infection and transmission - even though they do a better job (thank God) against serious disease) RB (thanks) posted some data from Denmark about household transmission showing 50% less after booster vaccination.


    So that is an R reduction of 50%

    Once more the vaccine terrorists fake claims. The study was from paper data with 50% fake positive. To correlate 50% with 50% you get down to 25% at best! Further vaccinated do far less testing.


    So as usual a 1000% clown post.

    Quote from zorud

    Wyttenbach, please post a graph that shows the real , not fake data from Switzerland….

    Here is another fake graph.

    I did link two papers that contains the base data. If you are a disabled person then I can record it for you...


    BAG_COVID-19_Woechentliche_Lage 50pdf.pdf

    BAG_COVID-19_Woechentliche_Lage 49pdf.pdf


    Here two weeks for you. Because the mafia does not like real data you must extract it yourself.


    And may be just read the text on the last line you did post. The text says the same.

    Swiss vaxx rate is close to 70% now. SO if 50% of all death are double vaxx how can it be 8x...

    Indonesia survey finds 85% of population have COVID-19 antibodies

    Indonesia survey finds 85% of population have COVID-19 antibodies
    More than 85% of Indonesia's population has antibodies against COVID-19, a government-commissioned survey showed, but epidemiologists warned it was not clear…
    www.reuters.com


    And yet with vaccination and natural imnity.......


    Indonesia’s Covid Cases Reach Two-Month High as Omicron Looms

    https://www.bloomberg.com/news/articles/2022-01-06/indonesia-s-covid-cases-reach-two-month-high-as-omicron-looms?utm_source=google&utm_medium=bd&cmpId=google



    I told you so!

    We again have record cases 32'000/day positive rate 33% with close to 100'000 tests/day. So in reality 250'000 cases...Keep in mind that these 8x folks have no symptoms or at least not more than a soft cold. So if hospital data today says 12x less severity with Omicron you have to multiply this 12 by 8 to finally get the 100x less real severity of Omicron!


    Just laugh loud at all fear monger folks....

    Quote from Wyttenbach

    We again have record cases 32'000/day positive rate 33% with close to 100'000 tests/day. So in reality 250'000 cases...Keep in mind that these 8x folks have no symptoms or at least not more than a soft cold. So if hospital data today says 12x less severity with Omicron you have to multiply this 12 by 8 to finally get the 100x less real severity of Omicron!


    Just laugh loud at all fear monger folks....

    My wife was showing symptoms for roughly 2 and a half days while mine cleared up a little sooner. We both are continuing to take our treatments and hopefully tomorrow we test negative and we can move on from the pandemic. Of coarse, the scare em campaign continues as the lastest headlines, new varients discovered in France with more mutations than omicron. It infected 12 people in late October, now that omicrom has shown a milder version got to work up the masses with something new!

    France detects new COVID-19 variant 'IHU', more infectious than Omicron: All we know about it
    The new variant — B.1.640.2 — which has been detected in 12 patients near Marseille, contains 46 mutations, making it more resistant to vaccines and infectious
    www.firstpost.com


    France detects new COVID-19 variant 'IHU', more infectious than Omicron: All we know about it

    The new variant — B.1.640.2 — which has been detected in 12 patients near Marseille, contains 46 mutations, making it more resistant to vaccines and infectious


    FP Staff

    January 04, 2022 13:23:51 IST

    Quote from Wyttenbach

    Jumping Jack logic. No, we have no Omicron wave - time series to short....


    You can choose yourselves what applies to you from (clown, child, Idiot, brick-head, undergrad, fool, gawk,....)

    The omicron wave has been going for 2 months (8 weeks) and the data is whole population cases and not that random.


    Your "concerning trend" was over 2 weeks and the data was serious illness under 60s (a set much much smaller than cases) hence there were in the graph you looked at only a few people making up your "trend".


    I hope this helps. I can see you are trying to make sense of things, and it is so easy to help you - although admittedly helping you does not always seem to help...


    THH

    Praise the Lord and Pass the Ivermectin


    Praise the Lord and Pass the Ivermectin
    Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.Joel S. Hirschhorn With over
    trialsitenews.com


    With over 1,200 daily COVID deaths for many weeks the US is on track to reach a total of one million COVID related deaths by the end of March. A shameful record for 2022.


    To think that every week over 8,000 Americans are dying, mostly in hospital ICUs is unbelievable. But that is no excuse that there is no serious attention by the mainstream media. Take a moment to reflect that this is more deaths than those in the 9/11 attacks and Pearl Harbor, combined. And it is happening every week.


    The late stage problem

    Hospitals have become killing machines, places where the kiss of death is a protocol following government guidelines. Despite wide COVID vaccine use deaths in hospitals because of late stage viral infection remain at a high level. Difficulty in getting COVID testing quickly and often probably contributes to the high death rate. Too many people do not get their COVID infection addressed early. There remains too little use of monoclonal antibodies early for infected people. So their infection progresses to serious lung and breathing problems. That is the beginning of the end.


    And it will be a long time before the new antiviral drugs from Pfizer and Merck are broadly available and there will be more information on whether they are really safe and effective for all diverse types of people.


    In hospitals, patients with breathing problems and upper respiratory distress are giving medical actions that may address pain but inevitably lead to death, often after many weeks in the ICU. They get the useless and harmful drug remdesivir, supplemental oxygen, steroids, and are intubated, put on a ventilator and usually put into a coma. And eventually they die and become another COVID statistic.


    It has been reported that the death rate for COVID patients prescribed remdesivir (26%) exceeds the fatality rate of COVID patients prescribed ivermectin, which is recorded by the Medicare database at 7.2%. And it has documented serious side effects.


    In a few successful court actions, such late stage COVID patients were given the cheap, safe generic IVM and – much to the astonishment of hospital doctors – have walked out of the hospital, completely recovered.


    And there is considerable medical research literature supporting such use of IVM, principally because of its anti-inflammatory property. As just one example, a published medical 2021 hospital study found nearly a 50% reduction in deaths for patients with severe pulmonary involvement, the typical late stage COVID death-bed patient condition. The many doubters of IVM should pay more attention to the medical science literature.


    But published medical articles are ignored by the medical and public health establishments.


    To be clear, a majority of hospitalized COVID patients have diabetes, are obese or have other serious underlying medical conditions. But though they get hospital attention, they do not all become late stage COVID patients with deadly breathing and lung problems. And the omicron variant is known to not be like delta; it does not attack lungs in the same way. And delta is still active and deadly.


    Hospital shame

    Hospitals stubbornly refuse to honor the few court decisions directing them to give death-bed late COVID stage patients a chance of surviving by administering ivermectin. Hospitals use an army of lawyers and every dirty legal trick to overturn or delay those few court decisions that reach the sensible conclusion that there is nothing to lose by using ivermectin.


    Indeed, here is the ugly truth: Hospital protocols for late stage COVID patients have nearly a one hundred percent record of failure. Their patients suffer and then die. Families desperate to get ivermectin used usually fail and watch their loved ones die.


    This is a medical disgrace. This is the power of corporate medicine. This situation exemplifies the loss of medical freedom. This is the epitome of medical tyranny. This is a total loss of medical ethics. This is an extreme example of doctors failing to live up to their Hippocratic Oath. They follow hospital rules and let their patients die without trying what has a medical justification. Without doing what other doctors have successfully done.


    Apparently, that weekly death total is not enough to push hospitals and doctors to use what several nations have used to curb the COVID pandemic and save many millions of lives.


    Hospital care arguments

    Consider this paradox and hypocrisy. Virtually all hospitals put a priority on patient-centered care. Patient-centered care focuses on the patient and the individual’s particular health care needs. The goal of patient-centered health care is to empower patients to become active participants in their care.


    Clearly, denying patient and family pleas for using ivermectin for people facing death is totally inconsistent with this philosophy and hospital commitment.


    Add to all this that demanding all patients use a one-size-fits-all medical treatment or hospital protocol is also counter to personalized medicine, long the hallmark of medicine. Doctors need the freedom to use what suits their patient rather than what the government dictates or accepting what it withholds.


    Court actions to get hospitals allowing IVM use might be more successful if both patient centered care and personalized medicine arguments were presented to judges.


    Conclusions

    Time to let those who want to use ivermectin in an attempt to save their life get it. It is medically and morally the right thing to do.


    With now a long record of hospital protocols for late stage COVID utterly failing to save lives, how can the medical profession justify not using a generic medicine that both research and clinical results justify and explain its ability to save lives?


    They cannot.


    Families trying to find a lawyer and a friendly court face a very, very difficult race to save their loved one stuck in the ICU just like a prisoner sentenced to death.


    Is it COVID killing these people or the medical profession and their hospital employers? Worth pondering as you keep watching mounting COVID death numbers

    With this type of report it means nothing unless the indications for prescription are the same.


    In UK remdesivir is only prescribed for serious disease. So if (I don't know) ivermectin is prescribed for less severe disease, you would expect the remdesivir figures to be worse if ivermectin and remdesivir had the same effect on death rate.


    That TSN piece is by Joel S Hirschhorn - a well-known much published home treatment without evidence advocate who thinks contrary to evidence that hydroxychloroquine works against COVID and who therefore you would not expect to check little details like "is the group of patients prescribed ivermectin the same as that prescribed remdesivir - or different in terms of average COVID severity?"


    A shame really. I find these comparisons interesting when they are done by people who want to know the answer.

    Quote from Fm1

    And it will be a long time before the new antiviral drugs from Pfizer and Merck are broadly available and there will be more information on whether they are really safe and effective for all diverse types of people.

    They are now broadly available in the UK, are used both for those who are every vulnerable and in over-50s studies. We have 4.25 million doses.


    UK secures millions more antivirals to help fight Omicron
    The UK has signed contracts to buy a further 4.25 million courses of antivirals for the NHS
    www.gov.uk


    Antiviral medicines such as molnupiravir are also available through a national study, run by Oxford University.

    The study is open to people living anywhere in the UK who:

    • have received a positive COVID-19 PCR test
    • have COVID-19 symptoms that started within the last 5 days
    • are aged 50 and over, or are aged 19 to 49 years with an underlying medical condition that can increase the risk of developing severe COVID-19

    If you take part in the study you may be randomly selected to:

    • receive a course of antiviral medicines
    • not receive the medicine

    This research study is needed to see if there are any differences in the health of those who take molnupiravir compared to those who do not.

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.